When is immunotherapy recommended for merkel cell carcinoma?

Merkel cell carcinoma is an uncommon skin cancer that can behave aggressively. Surgery and radiotherapy may be used when the disease is limited to the skin or nearby lymph nodes. Immunotherapy is often discussed when cancer has spread to other parts of the body, has returned, or needs treatment beyond a local procedure. The team considers scan findings, previous surgery or radiotherapy, immune conditions, organ function and medicines that could affect safety.

Bring details of previous skin procedures, radiotherapy and medicines to your oncology appointment. Tell the team about autoimmune disease, transplant history, steroid use and any ongoing infection. Ask how the response will be assessed and which symptoms should be reported. Do not delay reporting a new skin change, lump, cough, bowel change or marked tiredness during treatment.

Contact your cancer team promptly for a spreading rash, persistent diarrhoea, yellow skin, new cough, breathing difficulty, reduced urine, severe weakness or confusion. Seek urgent care for severe breathlessness, fainting, chest pain or rapidly worsening symptoms. Early review can distinguish an immune-related effect from infection or a change in the cancer.

Has the cancer spread or returned? Could surgery or radiotherapy still help? What is the goal of immunotherapy? How will skin, lymph nodes and distant areas be monitored? Which symptoms need same-day advice?